|
Todd Simpson joined Seattle Genetics in October 2005, bringing extensive industry experience from senior financial positions with several public biotechnology companies. Prior to joining Seattle Genetics, he served as Vice President of Finance and Administration and Chief Financial Officer at Targeted Genetics since October 2001. Previously, he was Vice President, Finance and Administration and Chief Financial Officer of Aastrom Biosciences. From 1992 to 1996, he served in financial roles at Integra LifeSciences Corporation and Telios Pharmaceuticals, Inc. (which was acquired by Integra in 1995). Mr. Simpson practiced public accounting with the firm of Ernst & Young LLP from 1983 to 1992, primarily focused in the life sciences and technology practices. He is a certified public accountant and received his B.S. in accounting and computer science from Oregon State University.
| 